Prime Minister Calls for Pharma R&D Push to Bolster Self-Reliance

Spread the Message

Read Time:1 Minute, 55 Second

NEW DELHI — In a major address on the nation’s 79th Independence Day, Prime Minister Narendra Modi issued a strong appeal to India’s scientific community and pharmaceutical entrepreneurs, urging them to prioritize research and development (R&D) and the strategic acquisition of patents. The Prime Minister’s call is a direct push to fortify India’s self-reliance in the critical health sector and to position the country as a global hub for medical innovation.

The appeal comes at a pivotal time, with a recent study from the Department of Pharmaceuticals (DoP) highlighting a significant gap in R&D investment. According to the DoP, India’s government shoulders the bulk of R&D funding, providing 75-80%, while the private sector contributes a mere 20-25%. This contrasts sharply with developed economies where private companies are the primary drivers of R&D, funding up to 69% of such initiatives. Additionally, the study noted that India’s share of the world’s researchers stands at a modest 2%.

This strategic focus on innovation is also timely due to an impending “patent cliff” from 2022 to 2032. This phenomenon, which will see many blockbuster drugs lose their patent protection, offers a golden opportunity for Indian generic companies. By developing and patenting new drugs, and creating more affordable versions of soon-to-be off-patent medications, India can significantly expand its footprint in regulated markets like the United States. This trend is already visible in the market for diabetes and weight-loss drugs.

The Prime Minister’s vision aims to bridge the investment gap and foster a culture of innovation, ensuring that India can not only meet its own healthcare needs but also emerge as a key player in shaping the future of global medical science.

Disclaimer: This news article is based on publicly available information and news reports. It is intended for informational purposes only and does not constitute medical advice or a recommendation for any specific treatment or product. Always consult with a qualified healthcare professional for medical advice.

Reference: